This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (55) Citing Articles via Google Scholar Google Scholar Articles by Duboc, D. Articles by Bécane, H.-M. Search for Related Content PubMed PubMed Citation Articles by Duboc, D. Articles by Bécane, H.-M. Related Collections Related Article

Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy

Denis Duboc, MD, PhD^*,*, Christophe Meune, MD^*, Guy Lerebours, MD, Jean-Yves Devaux, MD, PhD^*, Guy Vaksmann, MD^* and Henri-Marc Bécane, MD^*

^* French Working Group of Heart Involvement in Myopathies Investigators, Paris, France
Servier Laboratories, Paris, France

View larger version (22K): [in a new window]   Figure 1 Distribution of left ventricular ejection fraction (LVEF) in groups 1 and 2 at study entry, 36 months, and 60 months of follow-up. Corresponds to the difference in the number of patients with LVEF <45% in each group. Red circles = group 1 (initially assigned to perindopril); black circles = group 2 (initially assigned to placebo).